Dominic Piscitelli sold $8,103 of ORIC
Chief Financial Officer at Oric Pharmaceuticals, Inc.. 600 shares at an average of $13.50, traded Sep 24, 2026, filed Sep 25, 2026.
Score components
- +22RoleCFO
- 0Trade size$8k at market
- 0Share of holdings soldSold 0.9% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001695028-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | MOption exercise Common Stock10b5-1 | +600 | $4.36 | $2,616 | 70,428 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -100 | $13.50 | $1,350 | 70,328 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -500 | $13.51 | $6,753 | 69,828 | 17 d ago |
| Sep 24, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -600 | $0.00 | $0 | 91,900 | 17 d ago |
Related signals
Other insiders at Oric Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 2Weak | Oric Pharmaceuticals, Inc. | Richard A. Heyman director | $87k 6,700 shares | -16% | |
| 12Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $181k 13,400 shares | -16% | |
| 37Weak | Oric Pharmaceuticals, Inc. | Jacob Chacko PRESIDENT AND CEO | $204k 24,660 shares | -3% | |
| 28Weak | Oric Pharmaceuticals, Inc. | Pratik S Multani Chief Medical Officer | $73k 8,850 shares | -16% | |
| 30Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $73k 8,851 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.